老年患者心室辅助装置植入后院内死亡率:全国队列研究
加权样本共15,021±1111例患者,平均年龄56.6岁。老年患者若在VAD植入前接受至少一种高风险干预(心脏手术、延长机械通气、血液透析或体外膜肺氧合),院内死亡率从17.2%升至48.2%(P<.001),且此类干预相关的死亡率差异在老年患者中比年轻患者高19%(95%CI 9%-28%)。
要点
- 老年VAD患者若植入前接受高风险干预,院内死亡率近50%
- 年龄>65岁、女性及植入前高风险干预与院内死亡相关
- 细化患者选择可能有助于VAD更精准用于最可能获益者
核心结论
- 老年患者VAD植入前接受至少一种强化治疗者院内死亡率近50%,且不太可能接受心脏移植。
- 细化患者选择可能有助于使VAD更精准地用于最可能获益的患者。
主要发现
- 加权样本共15,021±1111例VAD植入患者,平均植入年龄56.6岁,大多数为白人(59.9%)和男性(75.0%)。
- 老年患者中,VAD植入前有至少一种高风险干预(心脏手术、延长机械通气、血液透析或体外膜肺氧合)时,院内死亡率从17.2%升至48.2%(P<.001)。
- 年轻患者中,同样高风险干预后院内死亡率从11.1%升至29.4%。
- 这些干预相关的死亡率差异在老年患者中比年轻患者高19%(95%CI 9%-28%)。
- VAD受者院内死亡与年龄>65岁(OR 1.76;95%CI 1.29-2.40)、女性(OR 1.27;95%CI 0.97-1.67)及至少一种植入前高风险干预(OR 5.52;95%CI 4.27-7.13)相关。
临床怎么用
- 对老年VAD候选者应仔细评估植入前是否已接受或需要高风险干预,以识别院内死亡风险极高的人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess baseline patient characteristics and identify factors associated with in-hospital mortality after ventricular assist device (VAD) placement. METHODS: Cross-sectional study using the National Inpatient Sample database from January 2010 to December 2014. Analyses were performed with sample weights provided by the National Inpatient Sample, which are reported ± the standard error of the mean. RESULTS: Weighted samples yielded 15,021 ± 1111 patients who received a VAD. The mean age at time of implantation was 56.6 years. Most recipients were white (59.9%) and male (75.0%). Among older patients, in-hospital mortality increased from 17.2% to 48.2% when 1 or more high-risk interventions (cardiac surgery, prolonged mechanical ventilation, hemodialysis, or extracorporeal membrane oxygenation) preceded VAD placement (P < .001). In comparison, in-hospital mortality in younger patients increased from 11.1% to 29.4% when 1 or more of these same procedures preceded VAD placement. The mortality difference associated with these procedures was 19% greater in older patients compared with younger patients (95% confidence interval [CI], 9%-28%). In-hospital mortality among VAD recipients was associated with age older than 65 years (odds ratio [OR], 1.76; 95% CI, 1.29-2.40), female sex (OR, 1.27; 95% CI, 0.97-1.67), and at least 1 high-risk intervention preceding VAD (OR, 5.52; 95% CI, 4.27-7.13). CONCLUSIONS: Older patients who underwent 1 or more intensive treatments before VAD placement had a nearly 50% inpatient mortality and were unlikely to receive a cardiac transplantation. Refining patient selection might help better align VAD with those most likely to benefit.
引用
- Lindvall C, Udelsman B, Malhotra D, et al. In-hospital mortality in older patients after ventricular assist device implantation: A national cohort study. J Thorac Cardiovasc Surg. 2018. PMID: 30579542. doi:10.1016/j.jtcvs.2018.10.142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。